Chonnam Med J. 2011 Dec;47(3):165-169. English.
Published online Dec 26, 2011.
© Chonnam Medical Journal, 2011
Original Article

Complications Following Outside-in and Inside-out Transobturator-Tape Procedures with Concomitant Gynecologic Operations

Moon Kyoung Cho, Chul Hong Kim, Woo Dae Kang, Jong Woon Kim, Seok Mo Kim and Yoon Ha Kim
    • Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Korea.
Received November 03, 2011; Accepted November 30, 2011.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This study was undertaken to compare the complications of outside-in transobturator tape procedures (TOT) and inside-out transobturator tape procedures (TVT-O) with concomitant gynecologic surgery for the treatment of female stress urinary incontinence (SUI). A retrospective review of 206 consecutive patients who underwent either TOT or TVT-O with concomitant gynecologic operations between March 2008 and February 2011 was conducted. The incidence of perioperative complications was compared. For statistical analysis, chi-squared tests were used. There were no reports of intraoperative complications such as vaginal injury or bladder perforation. Postoperative complications were noted in 23 procedures (11.2%). These included 6 cases of urinary retention (2.9%), 2 cases of vulva hematoma (1.0%), 7 cases of urinary tract infection (3.4%), 4 cases of de novo urgency (2.9%), and 4 cases of vaginal erosion (2.9%). There were no significant differences in complication rates between the two groups. Our results suggest that inside-out and outside-in procedures are simple and safe techniques that may have a low rate of complications when used with a concomitant gynecologic operation.

Keywords
Complications; Urinary stress incontinence; Gynecologic surgical procedures

INTRODUCTION

Stress urinary incontinence (SUI) affects up to 20% of women and is associated with significant medical complications and social embarrassment. Multiple behavioral and surgical treatments exist; however, the surgical placement of a suburethral mesh named the tension-free vaginal tape (TVT) is becoming the new gold standard for correction of SUI.1 This mesh is placed without tension between the mid-urethra and the vaginal anterior wall in order to strengthen or even rebuild the pubourethral ligaments and the suburethral vaginal hammock, in accordance with the integral theories described by Petros and Ulmsten.2 Several reports have confirmed high cure rates by use of the minimally invasive tension-free vaginal tape approach.3-6 Complications, however, primarily related to the penetration of the retropubic space, have been reported. Although most are minor, such as bladder perforation, other rare but potentially fatal complications such as vessel or bowel injury have been reported.4-6

To reduce these complications, an alternative approach, called the transobturator tape (TOT) procedure, was introduced by Delorme7 in 2001. This tape is also located underneath the midurethra, but runs laterally through the obturator membrane to the upper part of the thigh, from outside to inside. Results show that the success of the operation is comparable with retropubic procedures, but compared to these, the transobturator approach involves far fewer complications.8, 9 In 2003, a novel surgical technique was described by de Leval,10 with the passage of the tape through the obturator foramens from inside to outside, called tension-free vaginal tape inside out (TVT-O). This procedure permits a lower dissection, a precise and reproducible insertion, and a lower rate of injuries to the urethra and the bladder. These two techniques differ not only in the way the needle is placed and carried forward but also in the designs of the introducer. Recent prospective studies have indicated that TVT-O and TOT are equally effective and safe for women with SUI.11-13

It has been reported that 41% of women with SUI require concomitant surgical procedures for benign uterine disorders.14 Therefore, it is pragmatic to question whether concomitant gynecologic operations affect the complication rates of the incontinence procedures for SUI. However, until now, little evidence has been presented that one technique is superior to another when used with a concomitant gynecologic operation. We therefore compared the perioperative complications in two groups of patients who received either TVT-O or TOT procedures with concomitant gynecologic operations.

MATERIALS AND METHODS

1. Patient selection

Between March 2008 and February 2011, 206 consecutive female patients diagnosed with SUI who underwent either the TVT-O (n=61) or TOT (n=145) procedure with a concomitant gynecologic operation were included. Diagnosis of SUI was based on typical subjective symptoms (i.e., involuntary leakage on effort, exertion, coughing, sneezing, or laughing) as recommended in 2002 by the International Continence Society15 and on objective clinical data from the cough stress test, Q-tip test, or urodynamic studies.

Excluded were women with recurrent and difficult-totreat urinary tract infections, urge urinary incontinence, or mixed urinary incontinence in which the urge component was predominant, postvoiding bladder retention of more than 150 ml, bladder capacity of less than 100 ml, and physical or mental impairment.

2. Surgical techniques

The Serasis (Serag Wiesner, Germany) tape was inserted through the outside-in route by using the technique recommended by Delorme7 in 2001. The inside-out procedure was performed as described by de Leval10 in 2003, and a tape (TVT-O®, Gynecare, Johnson & Johnson, USA) was inserted. We will not describe them here. Both procedures used a monofilament, macroporous polypropylene tape.

All operations were carried out under general anesthesia. Cystoscopy was performed only in the case of encountering bloody urine. Thirty minutes before the scheduled operation, all patients received 1 g cefazolin sodium. A Foley catheter was always inserted. If there was no concomitant anterior colporrhaphy, the catheter was removed on the first postoperative morning. If there was concomitant anterior colporrhaphy, the catheter was maintained for 3 days.

3. Assessment of complications

An assessment of perioperative and postoperative complications was made for each patient. Perioperative complications were recorded after surgery by the surgeon. Immediate and late postoperative complications were also recorded during the patient's hospital stay and by the follow-up visit (after 1 month, 2 months, 1 year, and 2 to 3 years).

4. Statistical analysis

Data from the two groups were compared by using the chi-squared test with a 5% significance threshold. The results are expressed as means +/- standard deviations. Statistical analysis was performed by using SPSS, version 14.0 (SPSS, Chicago, IL, USA).

RESULTS

Patient characteristics are summarized in Table 1. The mean age of the 206 patients was 52.6±10.5 years. Our patients had given birth 2.9±1.4 times on average. All women underwent combined procedures (including abdominal hysterectomy, 14; vaginal hysterectomy with or without colporrhaphy, 145; sacrospinous ligament suspension, 7; colposacropexy, 4; LeFort partial colpocleisis, 10; other, 26). Other procedures included cystectomy of ovarian tumor, myomectomy, or adnexectomy. Ninety-one patients (44.2%) were postmenopausal. There were no significant differences in the baseline characteristics of the patients who underwent TOT or TVT-O. As shown in Table 1, there were significant differences concerning concomitant LeFort partial colpocleisis operations performed between the two groups.

TABLE 1
Baseline characteristics and concomitant operations

Intraoperative and postoperative complications are presented in Table 2. No major intraoperative complications, such as vaginal injury or bladder perforation, occurred. Urinary tract infections were noted in seven cases (3.4%): five (3.4%) after TOT and two (3.3%) after TVT-O procedures. They were resolved after antibiotic treatment. De novo urgency symptoms developed postoperatively in three TOT (2.1%) and one TVT-O (1.6%) patient (p=NS). All patients with de novo urgency were treated with anti-cholinergic medication and their symptoms were resolved within 1 to 2 months. Urinary retention (postvoiding residual urine volume>100 ml) was reported in six patients (2.9%): four (2.8%) after TOT and two (3.3%) after TVT-O procedures. Five of the patients with urinary retention required a urethral catheter for 3 days; following removal of the catheter on the 4th day, however, all voided well. In one patient who had persistent urinary retention for more than 1 week, we cut the mesh beneath the urethra and the condition was resolved. During the TOT procedure, there were two cases (1.4%) of vulva hematoma and four cases (2.8%) of vaginal erosion (no case during the TVT-O approach). The vulva hematomas were self-contained on the right side and resolved within 2 to 3 months without surgical intervention. Three cases of vaginal erosion were found within 3 to 4 months, and one case was after 1 year. Three cases of vaginal erosion were situated on the midurethral midline, and one case was on the lateral vaginal sulcus. All vaginal erosions were excised under local anesthesia, and all remained continent afterward. There were no serious complications in either group, such as obturator hematoma/abscess or significant nerve or vessel injury.

TABLE 2
Complication rates

In total, 18 (12.4%) complications with the TOT and 5 (8.2%) with the TVT-O procedures were reported. There were no significant differences between the two procedures regarding total complication rates (Table 2).

DISCUSSION

Compared with the retropubic approach (for example, TVT), the transobturator approach (for example, TOT) seems to be safer, because the complications related to the penetration of the retropubic space do not occur. There are two basic techniques for performing TOT: "outside-in" as described by Delorme7 and "inside-out" as described by Leval.10 Both procedures have become popular surgical treatments for female SUI16 and are applied in our department. This report comprises a comparative study of both procedures. The objective of this study was to compare operation-related morbidity for TVT versus TVT-O when used with concomitant gynecologic operations. We found no significant differences in the complication rates between the two approaches. Approximately 11.2% of the women experienced complications.

Although bladder perforation is a common complication occurring during TVT, the transobturator approach reduces the risks of bladder and urethral perforation. Theoretically, the transobturator tape does not penetrate the retropubic space, but the tip of the tunneller can injure the bladder, the bladder neck, or the urethra if its course is misaligned or in an oblique direction.17 Data from randomized controlled trials in which both groups had cystoscopy showed that no (0 of 232) women had bladder injury in the TVT-O/TOT group.18-20 Cadaver studies suggest that perioperative cystoscopy is not required, although there are case reports of this complication in the literature.21-23 Bladder perforation during TOT can be avoided by insertion of an index finger into the vaginal dissection. We had no case of bladder perforation during either procedure, which is consistent with other publications.

After the TOT procedure, two women returned because of hematoma of the vulva. Both cases were treated conservatively only, with nonsteroidal anti-inflammatory drugs and without antibiotics. There was no case of vulvar hematoma after the TVT-O procedure. However, there was no statistically significant difference between the two groups. It seems that the occurrence of postoperative hematoma may be greater after the inside-out procedure because of the fact that the needles go deeper during the inside-out procedure and perforate more muscular tissue, thus increasing the risk for vessel damage.

In a comparative study of two versions of the transobturator tape, TOT using the Obtape (Mentor-Porges, Le Plessis Robinson, France) developed more vaginal erosion than did TVT-O (7.29% vs 1.78%, p<0.05).24 In a prospective comparative study of the TVT-O and TOT (Monarc®, American Medical Systems, Minneapolis, MN, USA) procedures, Houwert et al. found a slightly higher erosion rate in the Monarc group.25 These results disagree with those of But and Faganelj.12 and Lee et al.13, which demonstrated that there were no tape erosions with either technique. The data from a meta-analysis of vaginal erosions in both procedures show that there seems to be a slightly higher erosion rate for the outside-in technique, but a significant difference was never reached, mostly because of small patient numbers.26 In the present study, there were four cases of vaginal erosion in the postoperative period after the TOT procedure (no cases after the TVT-O procedure). However, there was no significant difference between the two groups. Other factors related to vaginal erosion, apart from the surgical technique, such as biomechanical properties of the mesh used, infection, and the properties of tissue, need to be addressed to analyze the tape-erosion pattern. Achtari et al. showed by cadaveric dissection that TVT-O runs more closely to the obturator canal, making TVT-O more prone to possible injury of the obturator nerve and vessels.27 However, we observed no incidence of obturator nerve or vessel injury with the use of either procedure. Houwert et al. prospectively compared 191 women who underwent either a TVT-O (n= 93) or a TOT (n=96) procedure.25 They did not find any obturator nerve or vessel injury and suggested that this theoretical risk does not exist in clinical practice.

The drawback of the present study is its retrospective nature and different numbers of patients in each group. Furthermore, in our study, the TOT and TVT-O group differed significantly in the rate of concomitant LeFort partial colpocleisis operations. Despite these limitations, the large sample size, similar demographic variables of the study population, and performance of surgery in a single institution by the same surgical team probably increase the validity and mitigate the weaknesses.

In summary, the results of our study show that the complication rates of TVT-O and TOT with concomitant gynecologic operation were similar.

References

    1. Bemelmans BL, Chapple CR. Are slings now the gold standard treatment for the management of female urinary stress incontinence and if so which technique? Curr Opin Urol 2003;13:301–307.
    1. Petros PE, Ulmsten UI. An integral theory and its method for the diagnosis and management of female urinary incontinence. Scand J Urol Nephrol Suppl 1993;153:1–93.
    1. Doo CK, Hong B, Chung BJ, Kim JY, Jung HC, Lee KS, et al. Five-year outcomes of the tension-free vaginal tape procedure for treatment of female stress urinary incontinence. Eur Urol 2006;50:333–338.
    1. Nilsson CG, Falconer C, Rezapour M. Seven-year follow-up of the tension-free vaginal tape procedure for treatment of urinary incontinence. Obstet Gynecol 2004;104:1259–1262.
    1. Holmgren C, Nilsson S, Lanner L, Hellberg D. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol 2005;106:38–43.
    1. Meschia M, Pifarotti P, Bernasconi F, Guercio E, Maffiolini M, Magatti F, et al. Tension-Free vaginal tape: analysis of outcomes and complications in 404 stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 2001;12 Suppl 2:S24–S27.
    1. Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol 2001;11:1306–1313.
    1. deTayrac R, Deffieux X, Droupy S, Chauveaud-Lambling A, Calvanèse-Benamour L, Fernandez H. A prospective randomized trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. Am J Obstet Gynecol 2004;190:602–608.
    1. Wang AC, Lin YH, Tseng LH, Chih SY, Lee CJ. Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:439–443.
    1. de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 2003;44:724–730.
    1. Debodinance P. Trans-obturator urethral sling for the surgical correction of female stress urinary incontinence: outside-in (Monarc) versus inside-out (TVT-O). Are the two ways reassuring? Eur J Obstet Gynecol Reprod Biol 2007;133:232–238.
    1. But I, Faganelj M. Complications and short-term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:857–861.
    1. Lee KS, Choo MS, Lee YS, Han JY, Kim JY, Jung BJ, et al. Prospective comparison of the 'inside-out' and 'outside-in' transobturator-tape procedures for the treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:577–582.
    1. Smith PP, Appell RA. Pelvic organ prolapse and the lower urinary tract: the relationship of vaginal prolapse to stress urinary incontinence. Curr Urol Rep 2005;6:340–347.
    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002;187:116–126.
    1. Al-Singary W, Shergill IS, Allen SE, John JA, Arya M, Patel HR. Trans-obturator tape for incontinence: a 3-year follow-up. Urol Int 2007;78:198–201.
    1. Delmas V, Hermieu JF, Dompeyre P, Messas A, Dumonceau O, Ravery V, et al. The transobturator sling tape uratape: anatomical dangers. Eur Urol Suppl 2003;2:197.
    1. Laurikainen EH, Valpas A, Kiilholma P, Takala T, Kivela A, Aukee P, et al. A prospective randomized trial comparing TVT and TVT-O procedures for treatment of SUI: immediate outcome and complications. Int Urogynecol J Pelvic Floor Dysfunct 2006;17 Suppl 2:S104.
    1. Mansoor A, Vedrine N, Darcq C. Surgery of female urinary incontinence using trans-obturator tape (TOT): a prospective randomized comparative study with TVT. Neurourol Urodyn 2003;22:488–489.
    1. David-Montefiore E, Frobert JL, Grisard-Anaf M, Lienhart J, Bonnet K, Poncelet C, et al. Peri-operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. Eur Urol 2006;49:133–138.
    1. Bonnet P, Waltregny D, Reul O, de Leval J. Transobturator vaginal tape inside out for the surgical treatment of female stress urinary incontinence: anatomical considerations. J Urol 2005;173:1223–1228.
    1. Hermieu JF, Messas A, Delmas V, Ravery V, Dumonceau O, Boccon-Gibod L. Bladder injury after TVT transobturator. Prog Urol 2003;13:115–117.
    1. Minaglia S, Ozel B, Klutke C, Ballard C, Klutke J. Bladder injury during transobturator sling. Urology 2004;64:376–377.
    1. Abdel-Fattah M, Sivanesan K, Ramsay I, Pringle S, Bjornsson S. How common are tape erosions? A comparison of two versions of the transobturator tension-free vaginal tape procedure. BJU Int 2006;98:594–598.
    1. Houwert RM, Renes-Zijl C, Vos MC, Vervest HA. TVT-O versus Monarc after a 2-4-year follow-up: a prospective comparative study. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:1327–1333.
    1. Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG 2007;114:522–531.
    1. Achtari C, McKenzie BJ, Hiscock R, Rosamilia A, Schierlitz L, Briggs CA, et al. Anatomical study of the obturator foramen and dorsal nerve of the clitoris and their relationship to minimally invasive slings. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:330–334.

Metrics
Share
Tables

1 / 2

PERMALINK